The U.S. Food and Drug Administration (FDA) expanded its recall of a common Chinese-manufactured blood pressure and heart drug after a cancer-causing ingredient was found.
On Aug. 17, the FDA said that India-based Torrent Pharmaceuticals Limited announced that it “is voluntarily recalling 14 lots of Valsartan/Amlodipine/HCTZ tablets to the consumer level due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceuticals,” which is based in China.
